Photo from wikipedia
This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis. Click to show full abstract
This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis.
Keywords:
cumulative meta;
meta;
rare events;
analysis rare;
meta analysis
Journal Title: JAMA Network Open
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!